ArticleAnnals of Indian Academy of Neurology2025
Unlocking Hope: Development of India's First Indigenous Ketogenic Dietary Formula for Pediatric Epilepsy Care.
Article in Annals of Indian Academy of Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Author Reply - Indigenous Ketogenic Formula for Pediatric Epilepsy Care.Annals of Indian Academy of Neurology · 2025Article
- Indigenous Ketogenic Formulations in Pediatric Epilepsy: Promises and Pitfalls.Annals of Indian Academy of Neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesEpilepsy affects millions of children worldwide, with 30% of cases being resistant to conventional antiseizure medications, necessitating alternative treatments. The ketogenic diet, a high-fat, low-carbohydrate regimen, is effective in drug-resistant epilepsy, but access to affordable, culturally appropriate ketogenic products remains a challenge in developing countries. This study aims to develop the first indigenous ketogenic formula for children with drug-resistant epilepsy, using locally sourced, culturally appropriate ingredients.
methodsA ketogenic formula was developed using coconut milk powder, almond flour, soya flour, rice flakes, Bengal gram dal, and coconut oil, ensuring adaptability to ketogenic ratios (1:1 to 4:1). Organoleptic evaluation was conducted with neurologists, dietitians, parents, and children to assess taste, texture, and acceptability. Microbial safety and nutritional analysis ensured compliance with dietary requirements.
resultsThe developed ketogenic formula demonstrated high acceptability across all groups, with neurologists, dietitians, parents, and children giving hedonic scores of 8.8, 8.6, 8.4, and 8.2, respectively. Microbial testing confirmed safety, with no pathogenic bacteria detected. Nutritional analysis confirmed adherence to dietary standards with an energy content 564.99 kcal, fat content 37.99 g, protein content 9.1 g, and carbohydrates 46.67 g. The developed ketogenic formula also maintained its quality and safety throughout a 6-month shelf life study without use of any preservatives.
conclusionsThis study successfully developed a culturally appropriate, cost-effective ketogenic formula, addressing barriers to epilepsy management in resource-limited settings. Its high acceptability, safety, and adaptability suggest its potential for widespread use. Future clinical trials will assess its long-term efficacy and broader applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.